Most medical research is conducted during daylight hours. Acute laboratory animal studies frequently last merely 10 to 30 minutes, or a few hours at best. This practice is likely to continue. Yet much can be missed in studies so limited in duration. Long term effects, for example, might place the results of a study in an entirely different light, particularly so in the context of lung function.
Following the disappointing outcome of the extracorporeal membrane oxygenation (ECMO) (1) study, it was felt that more had to be learned from studying the pathophysiology of acute respiratory distress syndrome (ARDS) (2) . Of far greater import was the science on which ECMO was based in the first place. Was ECMO expected to prolong survival? What was the evidence that ECMO would succeed? There had been no preliminary laboratory animal studies, only acute studies showing a prompt improvement in arterial blood gases. But chronic benefits? The answer is NO. Hence, ECMO was conceived without the necessary laboratory proof showing survival.
Far from being unique to ECMO, this approach appears to be the rule. Often, new techniques are introduced on the basis of acute laboratory studies, or worse, no laboratory studies at all. For example, the introduction of hyperventilation in the treatment of persistent pulmonary hypertension of the neonate (PPHN) was based on impressions of clinical efficacy (3) . It now appears that hyperventilation's effects arise from the resulting systemic alkalosis and have little to do with low PaC0 2 (4, 5) . And at what price? The treatment produces a survival rate of some 50%; and far too many survivors wind up with chronic lung disease (6) brought on in great part by vigorous overventilation. Indeed, hyperventilation of PPHN was frequently followed some 2-3 days later by a transition phase PPHN with worsening in pulmonary function. Is this the result of treatment or is it the natural evolution of the disease? A sustained 24 hour per day around the clock study could have resolved the question.
Mechanical ventilation was likewise introduced into clinical practice after it was first successfully applied to polio patients with healthy lungs. Soon after that it was applied to patients with diseased lungs as well. Only in this case the lung compliance was impaired, frequently resulting in excessive peak inspiratory pressures. This was followed (not preceeded) by scattered reports of adverse reactions from mechanical pulmonary ventilation at elevated peak inspiratory pressures (7, 8) . More recently we have shown in laboratory studies that mechanical ventilation at high peak inspiratory pressures can in and of itself cause acute respiratory failure (9) . This issue was the subject of our earlier editorial (10).
In these above examples, virtually no thorough laboratory studies had been carried out beforehand, let alone long term studies. Yet any patient committed to mechanical ventilation because of a serious respiratory problem was destined to stay on not for a few hours but for days or weeks. What is the effect of such new treatment on the remaining (healthy) parts of the lung, or on the diseased parts of the lungs during the entire course of pulmonary disease? Such studies are difficult to carry out because they require care not unlike that found in critical care units, i.e. 24 hour exhaustive attendance to the animal's needs. Yet only in this way can we generate meaningful data, the end point being full recovery or lack of recovery. A transient improvement in arterial blood gases (and in total static lung compliance and in functional residual capacity), based on some acute change in the mechanical ventilator has no meaning of itself if after a few hours or by the next morning there is (again) a worsening in arterial blood gases, worsening in lung compliance, a worsening in functional residual capacity (9) . We cannot treat numbers; we must think ahead and treat the whole patient.
A five year review of two medical journals (Am Rev
The (ir)relevance of short term studies Resp Dis, and Chest), and of two pediatric journals (The Journal of Pediatrics, and Pediatric Research) from 1980-1985 had no stud ies that can be descri bed as long term, requiring constant attendance. Constant attendance to laboratory studies is time consuming and expensive. And yet we should not first embark on clinical studies based on short term studies, and then ask questions. It is gratifying to read of recent long term studies, for they are so much more meaningful (11, 12) .
Our own group has been among the few to conduct long term studies in laboratory animal models. These studies have been rewarding. The results are believable and meaningful. One treatment modality is explored from the beginning until survival and healthy lung function is either assured or not. In time, such
